H-KRFK-OH

Ref. 3D-PP49362

Informations sur le produit

• Nom: H-KRFK-OH

Description

Peptide H-KRFK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-KRFK-OH include the following: Expression of thrombospondin-derived 4N1K peptide-containing proteins in renal cell carcinoma tissues is associated with a decrease in tumor growth and Y Miyata, S Koga, K Takehara, H Kanetake - Clinical cancer , 2003 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/9/5/1734/204548 Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity Y Glinka, GJ Prud'homme - Journal of Leucocyte Biology, 2008 - academic.oup.comhttps://academic.oup.com/jleukbio/article-abstract/84/1/302/6975170 Use of a monoclonal antibody specific for activated endothelial cells to quantitate angiogenesis in vivo in zebrafish after drug treatment WL Seng, K Eng, J Lee, P McGrath - Angiogenesis, 2004 - Springerhttps://link.springer.com/article/10.1007/s10456-004-4181-7 Structure and dynamics of the peptide strand KRFK from the thrombospondin TSP-1 in water W Taleb Bendiab, B Benomrane, B Bounaceur - Journal of Molecular , 2018 - Springerhttps://link.springer.com/article/10.1007/s00894-018-3583-1 THE ACTIVATION SEQUENCE OF THROMBOSPONDIN-1 INTERACTS WITH THE LATENCY-ASSOCIATED PEPTIDE TO REGULATE ACTIVATION OF LATENT TGF SMF RIBEIRO, M POCZATEK - OF LATENT TGF-(3 , 1999 - search.proquest.comhttps://search.proquest.com/openview/ae083f233de4a8cc17799a9a104ef806/1.pdf?pq-origsite=gscholar&cbl=18750&diss=y#page=49 The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta SMF Ribeiro, M Poczatek, S Schultz-Cherry - Journal of Biological , 1999 - ASBMBhttps://www.jbc.org/article/S0021-9258(18)36918-7/abstract A peptide antagonist of thrombospondin-1 promotes abdominal aortic aneurysm progression in the angiotensin ii-infused apolipoprotein-e-deficient mouse SM Krishna , SW Seto, RJ Jose, E Biros - , and vascular biology, 2015 - Am Heart Assochttps://www.ahajournals.org/doi/abs/10.1161/ATVBAHA.114.304732 THE TGF-B-ACTIVATING SEQUENCE OF TSP1 ACTS VIA BINDING INTERACTIONS WITH A SEQUENCE IN THE LATENCY ASSOCIATED PEPTIDE S SCHULTZ-CHERRY - Activation Of Latent - digitalcommons.library.uab.eduhttps://digitalcommons.library.uab.edu/cgi/viewcontent.cgi?article=5742&context=etd-collection#page=174 Regulation of Transforming Growth Factor-beta Activation by Discrete Sequences of Thrombospondin 1 (∗) S Schultz-Cherry , H Chen, DF Mosher - Journal of Biological , 1995 - ASBMBhttps://www.jbc.org/article/S0021-9258(18)71763-8/abstract AND JOANNE E. MURPHY-ULLRICH S SCHULTZ-CHERRY , C HUI, DF MOSHER - Activation Of Latent - search.proquest.comhttps://search.proquest.com/openview/4f4892c58fdbbcc2e5bce84c45b15f08/1.pdf?pq-origsite=gscholar&cbl=18750&diss=y#page=141 Coating alginate microspheres with a serum albumin-alginate membrane: application to the encapsulation of a peptide R Hurteaux, F Edwards-Levy , D Laurent-Maquin - European Journal of , 2005 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0928098704002623 New Thrombospondin-1-Deriving Peptides as TGF-beta Activators of Cosmeceutical Interest P Ledwoà „ , F Errante , FR Fernandez , P Rovero - researchgate.nethttps://www.researchgate.net/profile/Rafal-Latajka/publication/365088996_New_Thrombospondin-1-Deriving_Peptides_as_TGF-I_Activators_of_Cosmeceutical_Interest/links/645a339097449a0e1a89ff19/New-Thrombospondin-1-Deriving-Peptides-as-TGF-I-Activators-of-Cosmeceutical-Interest.pdf Formulation of Peptides for Targeted Delivery P Ganatra , K Saiswani, N Nair, A Gunjal - Targeted Drug , 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/9783527827855.ch12 Identification of cell adhesive active sites in the N-terminal domain of thrombospondin-1 P CLEZARDIN , J LAWLER , J AMIRAL - Biochemical , 1997 - portlandpress.comhttps://portlandpress.com/biochemj/article-abstract/321/3/819/34171 Antiproliferative and antitumor activities of D-reverse peptides derived from the second type-1 repeat of thrombospondin-1 NHUA GUO, HC Krutzsch, JK Inman - Journal of peptide , 1997 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1399-3011.1997.tb01187.x Thrombospondin-1 is the key activator of TGF-beta1 in human mesangial cells exposed to high glucose N Yevdokimova, NA Wahab - Journal of the American , 2001 - journals.lww.comhttps://journals.lww.com/jasn/fulltext/2001/04000/Thrombospondin_1_Is_the_Key_Activator_of_TGF__1_in.9.aspx Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells N Guo, HC Krutzsch, JK Inman, DD Roberts - Cancer research, 1997 - AACRhttps://aacrjournals.org/cancerres/article-abstract/57/9/1735/504065 Thrombospondin1 in tissue repair and fibrosis: TGF-beta-dependent and independent mechanisms MT Sweetwyne , JE Murphy-Ullrich - Matrix Biology, 2012 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0945053X1200008X Identification of Inhibitors of Thrombospondin 1 Activation of TGF-beta MJ Suto, V Gupta , B Mathew , W Zhang - ACS Medicinal , 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsmedchemlett.9b00540 Thrombospondin-dependent activation of latent TGF-beta under normal or high glucose conditions MH Poczatek - 2001 - search.proquest.comhttps://search.proquest.com/openview/ae083f233de4a8cc17799a9a104ef806/1?pq-origsite=gscholar&cbl=18750&diss=y Serum albumin-alginate coated microspheres: role of the inner gel in binding and release of the KRFK peptide M Callewaert, JM Millot, J Lesage - International Journal of , 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0378517308006145 Topical application of TGF-beta-activating peptide, KRFK, prevents inflammatory manifestations in the TSP-1-deficient mouse model of chronic ocular inflammation L Soriano-Romanaca­ , L Contreras-Ruiz - International Journal of , 2018 - mdpi.comhttps://www.mdpi.com/1422-0067/20/1/9 Improved in vitro corneal delivery of a thrombospondin-1-derived peptide using a liposomal formulation L Soriano-Romanaca­ , J acalvarez-Trabado - Experimental Eye , 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S001448351730341X Expression of the type-1 repeats of thrombospondin-1 inhibits tumor growth through activation of transforming growth factor-beta KO Yee, M Streit, T Hawighorst, M Detmar - The American journal of , 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0002944010633196 Activation of latent transforming growth factor beta 1 and inhibition of matrix metalloprotease activity by a thrombospondin-like tripeptide linked to elaidic acid JH Cauchard, A Berton, G Godeau - Biochemical , 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006295204001315 Activation of latent TGF-beta1 by thrombospondin-1 is a major component of wound repair JE Nör , L DiPietro , JE Murphy-Ullrich - Oral biosciences & , 2005 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150167/ Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology JE Murphy-Ullrich , M Poczatek - Cytokine & growth factor reviews, 2000 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1359610199000295 Manipulation of Adult Dermal Wound Healing J Dodsworth - 2000 - search.proquest.comhttps://search.proquest.com/openview/61e7863f0a856a208ddf1b1d3f1238e4/1?pq-origsite=gscholar&cbl=2026366&diss=y A blocking peptide for transforming growth factor-beta1 activation prevents hepatic fibrosis in vivo H Kondou, S Mushiake, Y Etani, Y Miyoshi - Journal of , 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168827803003775 The tryptophan-rich motifs of the thrombospondin type 1 repeats bind VLAL motifs in the latent transforming growth factor-beta complex GD Young, JE Murphy-Ullrich - Journal of Biological Chemistry, 2004 - ASBMBhttps://www.jbc.org/article/S0021-9258(20)67895-4/abstract Molecular interactions that confer latency to transforming growth factor-beta GD Young, JE Murphy-Ullrich - Journal of Biological Chemistry, 2004 - ASBMBhttps://www.jbc.org/article/S0021-9258(20)73077-2/fulltext Extracellular Matrix Protein 1 Attenuates Hepatic Fibrosis by Inhibiting TSP-, ADAMTS-, and MMP-Mediated Latent TGF-beta1 Activation F Link, Y Li, J Zhao, S Munker, W Fan , Z Nwosu , Y Yao - bioRxiv, 2023 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2023.12.12.571289.abstract Anti-Aging Topical Peptides and Proteins F Khalid, F Gorouhi , HI Maibach - Cosmeceuticals and Active , 2015 - api.taylorfrancis.comhttps://api.taylorfrancis.com/content/chapters/edit/download?identifierName=doi&identifierValue=10.1201/b18895-17&type=chapterpdf Thrombospondin in renal disease C Hugo , C Daniel - Nephron Experimental Nephrology, 2009 - karger.comhttps://karger.com/nee/article/111/3/e61/378383 Decorin inhibits cell attachment to thrombospondin-1 by binding to a KKTR-dependent cell adhesive site present within the N-terminal domain of thrombospondin-1 B Merle, L Malaval, J Lawler , P Delmas - Journal of cellular , 1997 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1097-4644(19971001)67:1%3C75::AID-JCB8%3E3.0.CO;2-T Inhibition of retinal angiogenesis by peptides derived from thrombospondin-1 A Shafiee, JS Penn , HC Krutzsch - & visual science, 2000 - arvojournals.orghttps://arvojournals.org/article.aspx?articleID=2123438

• Marque: Biosynth